This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schneider-Gädicke, A. Articles by Bastert, G. Search for Related Content PubMed PubMed Citation Articles by Schneider-Gädicke, A. Articles by Bastert, G.

Identification of the Human Papillomavirus Type 18 E6* and E6 Proteins in Nuclear Protein Fractions from Human Cervical Carcinoma Cells Grown in the Nude Mouse or in Vitro¹

Institut für Virusforschung, Deutsches Krebsforschungszentrum, D69 Heidelberg, [A. S. G., E. S.]; Universitáts-Frauenklinik, D6650 Homburg, [S. K., G. B.]; and European Molecular Biology Laboratory, D69 Heidelberg, [H. G., R. F.]; Federal Republic of Germany

We recently reported the transcription patterns of human papillomavirus (HPV) type 18 sequences in human cervical carcinoma cell lines. The open reading frames (ORFs) E6* and E6 represent the 5'-terminal cistrons in HPV18 mRNAs. ORF E6* was assumed to be specific for HPV types associated with genital carcinomas. To identify the predicted gene product, ORF E6* from a HeLa cDNA clone was expressed as an MS2 fusion protein in Escherichia coli. The C-terminal 23 amino acid residues were chemically synthesized. A panel of monoclonal antibodies was generated, recognizing E6* and E6* plus E6, respectively. In human cervical carcinoma cell lines grown in vitro these monoclonal antibodies specifically immunoprecipitate the putative M_r 17,000 and 18,000 HPV18 E6 proteins in nuclear protein fractions. In a HPV18 DNA containing human cervical carcinoma established in nude mice, these monoclonal antibodies specifically immunoprecipitate a polypeptide with a molecular weight of 6500 as predicted for the HPV18 ORF E6* gene product in a nuclear protein fraction.

¹ This work was supported by The Deutsche Forschungsgemeinschaft and by the Behringwerke AG, Marburg.

² Present address: Department of Biochemistry and Molecular Biology, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138. To whom requests for reprints should be addressed.

Received 12/ 4/87. Revised 3/ 1/88. Accepted 3/ 7/88.

This article has been cited by other articles:

				D. L. Miller, B. Rickards, M. Mashiba, W. Huang, and S. J. Flint The Adenoviral E1B 55-Kilodalton Protein Controls Expression of Immune Response Genes but Not p53-Dependent Transcription J. Virol., April 15, 2009; 83(8): 3591 - 3603. [Abstract] [Full Text] [PDF]

				C. H. Storrs and S. J. Silverstein PATJ, a Tight Junction-Associated PDZ Protein, Is a Novel Degradation Target of High-Risk Human Papillomavirus E6 and the Alternatively Spliced Isoform 18 E6 J. Virol., April 15, 2007; 81(8): 4080 - 4090. [Abstract] [Full Text] [PDF]

				R. Koivusalo, E. Krausz, H. Helenius, and S. Hietanen Chemotherapy Compounds in Cervical Cancer Cells Primed by Reconstitution of p53 Function after Short Interfering RNA-Mediated Degradation of Human Papillomavirus 18 E6 mRNA: Opposite Effect of siRNA in Combination with Different Drugs Mol. Pharmacol., August 1, 2005; 68(2): 372 - 382. [Abstract] [Full Text] [PDF]